Hyperglycemia and development of glomerular pathology: Diabetes compared with galactosemia. Dogs were randomly assigned to experimental galactosemia or diabetes, or to a normal untreated group, and diabetic animals were then randomly assigned to either poor or good glycemic control. At five years duration, kidneys from the animals were compared by quantitative stereology. Glomerulopathy appeared in the poor control diabetes group, and the thickness of glomerular capillary basement membrane, the glomerular tuft volume, and the fraction of glomerulus occupied by mesangium were each significantly greater than normal. The capillary filtering surface area per glomerulus was supranormal also, but nonetheless was subnormal relative to glomerular volume. The development of glomerulopathy was significantly inhibited in dogs assigned to good glycemic control. In galactosemic animals, the basement membrane thickness was greater than normal, but the gbmerular volume, fractional and absolute volumes of mesangium, and capillary filtering surface area remained normal. The polyol concentration in renal cortex seemed elevated by galactosemia no less than by diabetes, and was highest in galactosemia. The galactosemic animals are known to have developed a retinopathy morphologically comparable to that of diabetic patients and diabetic dogs. Thus, sequelae of hyperglycemia sufficient to produce glomerular basement membrane thickening and retinopathy proved not necessarily sufficient to produce the mesangial expansion and gbomerular hypertrophy typical of diabetes.
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Hyperglycemia, the principal symptom of diabetes mellitus, is of uncertain significance in the etiology of diabetic nephropathy. Elevation of the blood glucose concentration can alter renal function, and has been shown to increase glomerular filtration rate (GFR) and renal plasma flow (RPF), and via nonenzymatic glycation of proteins, might increase the binding of plasma proteins to glomerular basement membrane and alter protein excretion [1] [2] [3] [4] [5] . Elevation of tissue polyoi concentration, another of the sequelae of hyperglycemia, possibly contributes to such functional changes, and diabetes-induced ab-has seemed upon light microscopy to be little affected [13] . Experimental galactosemia of five years duration apparently failed to elicit the nephropathy seen in dogs diabetic equally long, notwithstanding elevations of tissue polyol as great or greater than seen in diabetic dogs. In the present report, effects of long-term galactosemia on the ultrastructure of the renal glomerulus have been quantitatively evaluated in dogs and compared with the effects of diabetes.
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Methods
Healthy adult dogs (1-½ to 2-'/2 years old) were randomly assigned to be made diabetic or fed a 30% galactose diet [12] , or to remain as normal untreated (control) animals. The dogs were random source animals of mixed breeds. Diabetes was induced by injection of alloxan monohydrate intravenously, and after a brief interval of hyperglycemia to insure that the animals were comparably insulin-deficient, the diabetics were randomly assigned to either poor glycemic control or good glycemic control as described previously [14] . The poor control group received unlimited food with insulin once daily at a dosage inadequate to prevent chronic hyperglycemia and glucosuria, whereas the good control group received a measured diet with insulin twice daily at dosages chosen so as to minimize hyperglycemia and glucosuria. Hemoglobin A1 (HbA1) was measured two to four times per year using minicolumns (Isolab, Inc., Akron, Ohio), after incubation to remove labile adducts. Blood glucose and plasma galactose concentrations have been reported previously [12] .
Morphometry
At 60 months of study, animals were anesthetized with pentobarbital and, after tissue samples had been removed, were killed. Samples of renal cortex from mid-kidney were fixed for light microscopy in 10% neutral formalin, and for electron microscopy in 4% phosphate buffered glutaraldehyde followed by post-fixation in 1% osmium tetroxide. Ultrathin sections of the centermost gbomerulus from three different epon blocks were placed on Butvar-coated copper slot grids (1 X 2 mm), stained with uranyl acetate and lead citrate, and viewed in a JEOL 100 CX electron microscope (JEOL, Tokyo, Japan). Glomeruli were randomly entered, and then 15 to 25 evenly spaced micrographs were taken and printed at a final magnification of about 18,000x [151. A calibration grid was photographed each day along with the glomeruli. Obliterated glomeruli were not studied (although none were encountered in these epon blocks).
Glomerular volume was determined from sections (4 pm) of formalin-fixed paraffin-embedded kidney. The tissue sections were stained with periodic acid-Schiff and hematoxylin, and viewed in a microscope with a camera lucida attachment.
Outlines of glomerular tuft from 25 sequential glomeruli were traced onto paper, and the area of the tuft profile was determined using computer-assisted morphometry. Distances from a calibrated micrometer slide also were traced onto paper for use in calibrating the glomerular area measurements. The mean glomerular volume was calculated from mean glomerular area as described by Hirose and coworkers [16] .
Fractional volume (volume density) of each glomerular component was determined from the electron photomicrographs Polyol accumulation In an ancillary experiment, dogs were made galactosemic (N = 3) or diabetic (poor glycemic control, N = 4) as described above or were kept as normal controls (N 4), and were killed after two to four months of study. Fresh kidney slices were frozen at -80°C for assay of polyol concentration in renal cortex. Polyol was assayed by gas chromatography in the case of galactosemia (mostly galactitol), or by enzymatic methods (to achieve the desired sensitivity for sorbitol) in tissue from diabetic and normal animals [19, 201 . The level of renal sorbitol was similar in the two methods.
Group comparisons were made using parametric methods (ANOVA followed by a Tukey-Kramer test) or nonparametric methods (Kruskal-Wallis followed by Mann-Whitney U tests of HbA1 concentration and tissue polyol concentration). Data are reported as mean SD.
Results
Diabetic dogs assigned to the poor control group developed chronic hyperglycemia, glycosuria, polyuria, and hyperphagia, and their mean HbA, concentration for the five years of study was significantly greater than normal (P < 0.01, Table 1 , Fig. 1 ).
In diabetic dogs assigned to good control, such metabolic abnormalities were absent or minimal and HbAJ was comparable to normal. Nondiabetic animals fed the galactose-rich diet showed levels of HbA, significantly greater than normal (P < 0.05) although less than the value for diabetics in poor control.
Poor control of diabetes resulted in glomerular hypertrophy and mesangial expansion ( Table 2 ). The volume of the glomerulus greatly exceeded that of normal dogs and, moreover, the mesangium was disproportionately enlarged and occupied a greater than normal fraction of the glomerular volume. The absolute volume of mesangium, accordingly, also exceeded normal. The increase in the fractional volume of mesangium involved increases in the fractional volumes of both the mesangial cells and matrix. The mesangium's fractional volume varied appreciably between animals, about 6 to 23% in normal dogs and 9 to 34% in poorly controlled diabetics. Other glomerular components in the poorly controlled diabetics (such as, capillary endothelium and visceral epithelium) also showed significant increases in absolute volume, and the capillary basement membrane was significantly thicker than normal. Capillary filtering surface density (Sly), was subnormal in the poor control group, but the reduction seems due to glomerular hypertrophy rather than to a loss of filtering surface area. The filtering surface's absolute area in the poor control group was, in fact, greater than normal. The ratio of capillary length to glomerular volume (L/V) was not abnormal in any group (data not shown).
Good glycemic control inhibited the development of the above glomerular abnormalities in diabetes. The good control group differed significantly from the poor control group, and not from normal, with respect to basement membrane thickness, glomerular volume, capillary filtering surface area per glomerulus, capillary length per glomerulus, S/V ratio, and volume occupied by endothelium and epithelium ( Table 2 ). The fraction of glomerulus occupied by mesangium in the good control group was less than in poor controls, although not to a statistically significant degree.
In contrast to the severe glomerulopathy seen in chronically hyperglycemic diabetic dogs, the renal glomerulus of dogs galactosemic for five years seemed little affected. The glomerulus in galactosemia was not hypertrophic and was not significantly different from normal with respect to either the fractional volume or absolute volume (per glomerulus) of mesangium, endothelium or epithelium. Neither the S/V ratio nor the total capillary filtering surface area was abnormal. Nevertheless, the capillary basement membrane was significantly thicker than in In an ancillary study of polyol concentration in the renal cortex, diabetes of two to four months duration was shown to result in tissue polyol (sorbitol) levels significantly greater than in normal dogs (P <0.05; Table 3 ). Galactosemic (nondiabetic) dogs had tissue polyol (galactitol) concentrations several-fold greater than those of normal or diabetic dogs.
Discussion
Diabetic dogs in poor glycemic control develop a nephropathy closely resembling that characteristic of diabetes in patients. The renal abnormalities include nephromegaly, mesangial expansion, glomerular obliteration, occasional exudative deposits and mesangial nodules, and excessive excretion of protein [13, [21] [22] [23] [24] . In addition, the glomerular volume and capillary filtering surface area become greater than normal in diabetic dogs, as is the case also in diabetic patients prior to the appearance of clinical nephropathy. Later in the course of the nephropathy in patients the filtering surface area becomes reduced, an anatomic change yet to be demonstrated in animals, and associated with serious impairment of renal function [25] .
Good glycemic control from the onset of diabetes tends to inhibit the development of nephropathy in rats [26] [27] [28] and, as is clear from the present studies, also in dogs. The nephropathy observed in animals kept in poor glycemic control cannot be attributed therefore simply to nephrotoxic effects of alloxan or aging. These findings lead one to hope that the development of diabetic nephropathy in patients also might be inhibited by improvement of glycemic control, at least if good control is established soon after the onset of diabetes. The evidence that the nephropathy can be inhibited by good glycemic control provides no information as to whether the inhibition is due to correction of the hyperglycemia itself, or is due instead to the coincident correction of other metabolic sequelae of deficient insulin activity (dysmetabolism of lipids, proteins, etc.). Hyperglycemia, although an appropriate target for clinical treatment, is of uncertain significance in the pathogenesis of nephropathy.
In contrast to the marked nephropathy observed in diabetic dogs after five years of hyperglycemia, kidneys from dogs experimentally galactosemic equally long seem little affected. Glomerular volume as well as the volume of the mesangium and cellular components of the tuft, and the capillary filtering surface area are not abnormal in galactosemic dogs, and clearly are less affected than in diabetes. The results of the present ultrastructural analysis are consistent with our observations by light microscopy [13] . By light microscopy, the mesangial area (estimated semi-quantitatively), frequency of obliterated gbmeruli, and kidney weight were found to be normal in experimental galactosemia, and significantly less than in diabetes. Nonetheless, the basement membrane of glomerular capillaries is found by us to be significantly thickened by experimental galactosemia. This basement membrane thickening occurs in the absence of any increase whatever in mesangial matrix, a basement membrane-like material known to become excessive in diabetes. Accumulation of mesangial matrix therefore seems unlikely to be produced by the same sequelae of hyperglycemia that cause accumulation of basement membrane in the capillary wall. Similarly, abnormalities of the glomerular capillary basement membrane and mesangial matrix in diabetic animals have been reported to be not equally reversible by islet transplantation [15, 18] . Dogs made experimentally galactosemic for several years develop a retinopathy that is remarkably similar to that seen in diabetic patients and diabetic dogs [12] . The retinopathy includes saccular capillary aneurysms, pericyte "ghosts", nonperfused acellular capillaries, and hemorrhage. Thus, galactosemia sufficient to produce diabetic-like lesions in the glomerular basement membrane and retina has proved to be not sufficient to elicit several renal abnormalities that are typical of diabetes, notably mesangial expansion, glomerular hypertrophy and obliteration, and nephromegaly.
Consumption of the galactose-rich diet results in elevation of the blood levels of an isomer of glucose (galactose) in the apparent absence of many other metabolic abnormalities of diabetes, such as insulinopenia and supranormal blood levels of glucose, fatty acids, branched-chain amino acids and fibrinogen [12] . Diabetic-like lesions produced by feeding the galactose appear to be secondary to the hyperglycemia (galactosemia) itself and its sequelae. Two sequelae of hyperglycemia, excessive non-enzymatic glycation of protein and excessive production or accumulation of polyol, have received much attention in recent years, and the magnitude of each in our galactosemic animals appears to be unlike that in our insulin-deficient animals. Tissue levels of non-enzymatically glycated protein, represented in the present study by HbA1, tend to be less in galactosemic dogs than in insulin-deficient dogs. This may be due in part to a difference in severity of hyperglycemia, since blood hexose levels in insulindeficient dogs tend to remain elevated at all hours of the day, whereas in galactose-fed dogs the blood hexose rises postprandially but subsequently approaches normal during sleep or fasting.
Tissue polyol concentration, in contrast, tends to be greater in galactosemic dogs than in insulin-deficient dogs, as shown for renal cortex in the present study and for erythrocytes in a prior study [13] . Excessive production and accumulation of polyols has been implicated in capillary basement membrane thickening in diabetes and experimental galactosemia, inasmuch as the thickening in retinal vessels of diabetic and galactose-fed rats reportedly can be prevented by administration of an aldose reductase inhibitor [29] [30] [31] . Comparison of the effects of experimental galactosemia and diabetes described herein and in a previous report [131 raise a possibility, however, that mesangial expansion, glomerular hypertrophy and obliteration, and seemingly other renal lesions typical of diabetes are not a result of excessive tissue polyol concentrations alone, and thus may respond less well than perhaps other diabetic complications to treatment with aldose reductase inhibitors.
